Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Miyazaki

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Hemasphere|November 9, 2020
Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7Hiroyoshi Kunimoto, Yumi Fukuchi, Koichi Murakami, et al.
Annals of Hematology|July 3, 2025
Clinical significance of C-reactive protein/platelet ratio from diagnosis to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaAkihiko Izumi, Takayoshi Tachibana, Jun Nukui, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799Jun Ohwada, Hirosato Ebiike, Hatsuo Kawada, et al.
International Journal of Hematology|January 7, 2018
Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302)Takayoshi Tachibana, Junya Kanda, Shinichiro Machida, et al.
International Journal of Hematology|March 30, 2026
Safety and efficacy of clofarabine for preconditioning intervention in patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphoblastic leukemiaAkihiko Izumi, Takayoshi Tachibana, Takuya Miyazaki, et al.
Leukemia Research|April 9, 2025
Clinical applicability of the ELN2020 criteria for tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia: insights from a multicenter retrospective study in real-world practiceYuto Hibino, Shin Fujisawa, Katsumichi Fujimaki, et al.
American Journal of Hematology|July 27, 2007
Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infectionTakuya Miyazaki, Katsumichi Fujimaki, Yukari Shirasugi, et al.
International Immunology|January 16, 2026
T cell help is a limiting factor for rare anti-influenza memory B cells to reenter germinal centers and generate potent broadly neutralizing antibodiesYang Xue, Yuki Tai, Hiromi Yamamoto, et al.
International Journal of Hematology|March 15, 2024
A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variantTakuma Ohashi, Hiroyoshi Kunimoto, Jun Nukui, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|July 31, 2024
Rare severe constrictive pericarditis complication in Erdheim-Chester disease: A case report and literature reviewTakuya Miyazaki, Daisuke Kamimura, Mao Wakamatsu, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Hemasphere|November 9, 2020
Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7Hiroyoshi Kunimoto, Yumi Fukuchi, Koichi Murakami, et al.
Annals of Hematology|July 3, 2025
Clinical significance of C-reactive protein/platelet ratio from diagnosis to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaAkihiko Izumi, Takayoshi Tachibana, Jun Nukui, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799Jun Ohwada, Hirosato Ebiike, Hatsuo Kawada, et al.
International Journal of Hematology|January 7, 2018
Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302)Takayoshi Tachibana, Junya Kanda, Shinichiro Machida, et al.
International Journal of Hematology|March 30, 2026
Safety and efficacy of clofarabine for preconditioning intervention in patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphoblastic leukemiaAkihiko Izumi, Takayoshi Tachibana, Takuya Miyazaki, et al.
Leukemia Research|April 9, 2025
Clinical applicability of the ELN2020 criteria for tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia: insights from a multicenter retrospective study in real-world practiceYuto Hibino, Shin Fujisawa, Katsumichi Fujimaki, et al.
American Journal of Hematology|July 27, 2007
Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infectionTakuya Miyazaki, Katsumichi Fujimaki, Yukari Shirasugi, et al.
International Immunology|January 16, 2026
T cell help is a limiting factor for rare anti-influenza memory B cells to reenter germinal centers and generate potent broadly neutralizing antibodiesYang Xue, Yuki Tai, Hiromi Yamamoto, et al.
International Journal of Hematology|March 15, 2024
A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variantTakuma Ohashi, Hiroyoshi Kunimoto, Jun Nukui, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|July 31, 2024
Rare severe constrictive pericarditis complication in Erdheim-Chester disease: A case report and literature reviewTakuya Miyazaki, Daisuke Kamimura, Mao Wakamatsu, et al.
Pageof 11